Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Clinical trial NCT00370396 · COMPLETED
Trial details
- NCT number
- NCT00370396
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-25
- Primary completion
- 2007-06-04
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.